At the recommendation of Scientific Advisory Board member Dr. John Kirkwood, NCC has been funding post doctoral research in melanoma for over two decades. We commend Yale researchers for their new findings.
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.
“For a lot of patients, treating skin cancer is much more involved than it would be if there was a way to effectively treat them with a simple procedure like an injection,” said Dr. Michael Girardi, professor and vice chair of dermatology at Yale School of Medicine and senior author of the study. “That’s always been a holy grail in dermatology — to find a simpler way to treat skin cancers such as basal cell carcinoma and squamous cell carcinoma.”
Click here to read full article at Yale